Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Haemocomplettan® P During Aortic Replacement

This study has been completed.
Information provided by (Responsible Party):
CSL Behring Identifier:
First received: June 16, 2008
Last updated: September 18, 2013
Last verified: February 2011